Dillon & Associates Inc Celgene Transaction History

Dillon & Associates Inc

$711 Million
Q3 2024

Shares

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2019 Feb 03, 2020	SELL	N/A	-2,659 Closed	0 $0
Q3 2019 Oct 25, 2019	SELL	N/A	-10,534 Reduced 79.85%	2,659 $263,000
Q2 2019 Jul 22, 2019	SELL	N/A	-47,693 Reduced 78.33%	13,193 $1.21 Million
Q1 2019 May 07, 2019	SELL	N/A	-3,450 Reduced 5.36%	60,886 $5.72 Million
Q4 2018 Feb 14, 2019	SELL	N/A	-8,220 Reduced 11.33%	64,336 $4.12 Million
Q3 2018 Nov 14, 2018	BUY	N/A	1,065 Added 1.49%	72,556 $6.46 Million
Q2 2018 Aug 08, 2018	BUY	N/A	9,835 Added 15.95%	71,491 $5.65 Million
Q1 2018 May 08, 2018	BUY	N/A	9,612 Added 18.47%	61,656 $5.49 Million
Q4 2017 Feb 08, 2018	BUY	N/A	4,321 Added 9.05%	52,044 $5.41 Million
Q3 2017 Nov 13, 2017	BUY	N/A	850 Added 1.81%	47,723 $6.97 Million
Q2 2017 Aug 09, 2017	BUY	N/A	46,873	46,873 $6.09 Million

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dillon & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dillon & Associates Inc with notifications on news.